Philip Louis McCarthy MD
Hematologic Oncology
Professor of Oncology and Internal Medicine, Roswell Park Cancer Institute and SUNY at Buffalo School of Medicine
Join to View Full Profile
Elm and Carlton StBuffalo, NY 14263
Phone+1 716-845-2300
Fax+1 716-845-3272
Dr. McCarthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Philip McCarthy, MD, based in Buffalo, NY, specializes in hematology with a subspecialty in hematologic oncology. He completed his residency in internal medicine at Yale-New Haven Medical Center and a fellowship in hematology and medical oncology at prestigious institutions, including Dana-Farber Cancer Institute. He is a Professor Emeritus at Roswell Park Comprehensive Cancer Center and a Professor at the University at Buffalo. Dr. McCarthy has extensive experience in hematologic oncology, hematopoietic stem cell transplantation, and multiple myeloma. He has led numerous clinical trials, particularly in multiple myeloma and B-cell non-Hodgkin lymphoma, and has contributed significantly to publications in high-impact journals. His work has been recognized with multiple CMS Meaningful Use Stage 1 Certifications. He continues his clinical and preclinical collaborations to improve the clinical care of hematologic malignancy patients with an emphasis on multiple myeloma.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1985 - 1989
Yale-New Haven Medical CenterResidency, Internal Medicine, 1982 - 1985
Tufts University School of MedicineClass of 1982
Certifications & Licensure
NY State Medical License 1996 - 2027
MA State Medical License 1987 - 2016
TX State Medical License 1992 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care Module Set, Allscripts, 2013
- CMS Meaningful Use Stage 1 Certification Sunrise Patient Portal and Sunrise Acute Care EHR, Allscripts, 2013
- CMS Meaningful Use Stage 1 Certification Sunrise Acute Care Module Set, Allscripts, 2013
Clinical Trials
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer Start of enrollment: 1998 Oct 19
- Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer Start of enrollment: 1998 Sep 01
- Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia Start of enrollment: 2002 Jun 01
Publications & Presentations
PubMed
- Pretreatment physical function as a risk factor for movement and neurocognitive treatment-emergent events (MNTs) in multiple myeloma (MM) patients treated with cilta-cel.Megan M Herr, Nisha M Nair, Theresa Hahn, Chelsea Peterson, Jens Hillengass
Journal of the Neurological Sciences. 2026-03-15 - Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.Theresa Hahn, Megan M Herr, Paul K Wallace, Yali Zhang, Shernan Holtan
Leukemia & Lymphoma. 2026-02-01 - 6-Phosphogluconate dehydrogenase promotes mitochondrial fusion and immune suppression in tumor-associated monocytic suppressor cells.Saeed Daneshmandi, Qi Yan, Eduardo Cortes Gomez, Jee Eun Choi, Eriko Katsuta
Nature Communications. 2026-01-14
Abstracts/Posters
- Genome Wide Interaction Analysis Identifies Expression Quantitative Trait Loci Associated with Reduced Survival after Reduced Intensity Conditioning HLA-Matched Unrela...Philip L. McCarthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Tran...Philip L. McCarthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)Philip L. McCarthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023
Roswell Park Oncology Experts Named to Castle Connolly ‘Top Doctors’ ListAugust 4th, 2022- Roswell Park Researchers Identify Key Link Between Stress and CancerNovember 5th, 2021
Professional Memberships
- Member
- Member
- Member
- Member
- Member
External Links
- Roswell Park Cancer Institutehttps://www.roswellpark.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
